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1. Introduction
Influenza (also known as flu), is an acute viral infection of the respiratory tract,
which includes the nose, mouth, throat, bronchial tubes and lungs. It is
characterised by:
a fever
chills
headache
muscle and joint pain
fatigue
For otherwise healthy people, flu is an unpleasant but usually self-limiting
disease with recovery within 2 to 7 days. Flu is easily transmitted and even
people with mild or no symptoms can still infect others.
The risk of serious illness from flu is higher among children under 6 months of
age, older people, pregnant girls and women and people with underlying health
conditions. This includes conditions such as respiratory disease, diabetes,
cardiac disease or immunosuppression.
Maintaining the operational effectiveness of prisons and other secure settings
is essential to preserve a fully functional criminal justice and immigration
removal system. So, minimising the impact of seasonal flu within these settings
is important.
The 2020 to 2021 winter season will be different from previous years
due to coronavirus (COVID-19). Given the similarities in symptoms
between flu and COVID-19, the children and young people’s secure
estate should manage potential outbreaks as acute respiratory viral
illness, with quick testing to determine the diagnosis.
1.1 Background
The children and young people’s secure estate (CYPSE) runs the risk of
significant and potentially serious flu outbreaks, with large numbers of cases
and a higher rate of complications. This is because:
of the enclosed nature of the CYPSE and fact that children and young people
are often living close together, with social mixing during activities
of movement of children and young people within the estate
access to healthcare could be limited if demand is high and care is
complicated
children in the CYPSE have a higher prevalence of respiratory illness
(including asthma) and other long-term conditions such as diabetes than
their peers in the community
An important principle in managing seasonal flu is that children in the CYPSE
should receive the same healthcare as their peers in the community. This
includes access to antiviral treatment, although delivering such healthcare
may differ from community models.
An essential element of reducing the impact of flu in the CYPSE is a whole
setting approach to the prevention, early identification and notification of
illness, and prompt access to treatment, including antivirals.
1.2 COVID-19
On 5 March 2020, illness resulting from COVID-19 was added to the list of
notifiable diseases in England. Shortly afterwards it was included on the list of
reportable diseases in prisons and other secure settings, such as immigration
removal centres and the children and young people’s secure estate.
COVID-19 symptoms are like other influenza-like illnesses so appropriate
diagnostic testing is needed to ensure the correct diagnosis is made. Public
Health England (PHE) and the Ministry of Justice published information and
guidance on preventing and controlling outbreaks of COVID-19 in prisons.
The flu vaccination programme for the 2020 to 2021 flu season has been
extended, with more groups eligible to receive a flu vaccine than in previous
years. This includes school children in Year 7, which was planned for as part of
the expected expansion of children who receive the flu vaccine routinely.
Since COVID-19 is likely to be circulating together with flu, protecting young
people and staff at high risk of flu, who are also those most vulnerable to
hospitalisation as a result of COVID-19, is vitally important.
Control measures to prevent the spread of the COVID-19 virus such as shielding
and social distancing will mean that delivering the flu vaccine this year will be
more challenging. This is because flu vaccines are likely to be delivered in a
very different way than in previous years and you should consider a range of
different ways for delivering the programme this year.
Flu immunisers are also likely to need to wear personal protective equipment
(PPE) in keeping with the current advice on delivering the flu vaccine. Health
Education England’s e-Learning for Healthcare has produced a flu-specific, e-
learning programme that is available free of charge. Anyone who gives or
advises on flu vaccines can do this e-learning programme, which consists of a
core module and separate sessions on the inactivated and live flu vaccines.
1.3 Last year’s flu season
The 2019 to 2020 flu season saw fewer confirmed outbreaks of seasonal flu
reported in prisons across England and Wales than in 2018 to 2019. In total,
prisons reported 7 confirmed outbreaks of flu A or B compared with 13 in the
year before. Most of the reported outbreaks occurred in adult prisons in
England, but one outbreak occurred in a prison in Wales and 2 outbreaks were
reported in immigration removal centres in England. In the CYPSE, 15
confirmed cases were reported in 6 settings (11 service users, 4 staff) and 1
death of a staff member.
As well as fewer reported outbreaks than the year before, there were fewer
cases reported, on average, in each outbreak. There were 6.4 cases per
outbreak in 2019 to 2020 compared with 10.6 cases per outbreak in 2018 to
2019.
A smaller proportion of cases had serious complications secondary to their
infection which required hospitalisation. There were no prisoners or detainees
hospitalised in 2019 to 2020 compared to 7.1% in the year before.
No prisoners died as a result of complications secondary to their flu infection.
2. Preparation and vaccination
2.1 Preparation
The public health principles guiding action within the CYPSE are the same as
those in the wider community. This includes:
appointing a flu lead to oversee preparations including the seasonal flu
vaccine campaign
vaccinating everyone in clinical risk groups (refer to the influenza chapter in
the Green Book)
vaccinating healthcare staff working in the CYPSE in line with national
guidance in the Green Book
vaccinating young offender institution custodial staff and Youth Custody
Service (YCS) headquarters staff, who are eligible for flu vaccine via their
employer through Her Majesty’s Prison and Probation Service (HMPPS)
business hub (this is beyond the Green Book guidance)
vaccinating for secure training centre custodial staff, who are eligible for flu
vaccine via their operator (this is beyond the Green Book guidance)
vaccinating secure children’s homes residential staff
collecting respiratory specimens to obtain quick diagnosis, including
assessing whether it is an outbreak
making sure there is effective and appropriate care available, including
access to antivirals for people who are ill or to prevent infection in those at
risk of complications
good infection control practice and resources
The CYPSE should agree clear arrangements with their PHE health protection
team (HPT) and NHS England and Improvement health and justice children’s
commissioners to make sure they know how to:
order vaccine supplies in good time before the annual vaccination period
plan and coordinate vaccination of eligible individuals (staff and children)
record and monitor (and make available on request) local information on
numbers and percentages of staff and residents who have received a
vaccination
recognise possible outbreaks and report them quickly (see the PHE
guidance on managing outbreaks in prisons)
access public health advice and support, in and out of office hours
rapidly access viral testing (and processing of swabs) to support the need for
quick diagnosis and careful consideration for early treatment for clinical risk
groups
provide antiviral medication
ensure there is enough PPE in stock
2.2 Vaccination for children and young people
The immunisation programme protects people who are at risk of serious illness
and reduces transmission. Healthcare teams should make a register of children
who are recommended to receive the flu vaccine. They can then order enough
vaccine in advance and invite individuals to planned immunisation sessions or
appointments.
The recommended flu vaccines for children and young people are detailed in
the annual flu letter.
Healthcare teams should offer vaccinations before flu viruses start to circulate
in late September and early October to the defined clinical risk groups outlined
in the annual flu letter.
All children aged 2 to 11 years old (but not 12 years or older) on 31 August 2020
should be given the flu vaccination. There are a large number of children in
secure settings who might not have been in mainstream education and so
could have missed the opportunity to receive routine childhood vaccinations.
Children and young people between 12 and 18 years old who are in a clinical at-
risk group as set out in the chapter on influenza in the Green Book.
This list is not exhaustive. The healthcare practitioner should apply clinical
judgement to consider the risk of flu making worse any underlying disease that
a patient may have, as well as the risk of serious illness from flu itself. In these
cases, the young person should be offered a flu vaccine, even if they are not in a
clinical risk group.
2.3 Specific groups to be considered for vaccination
Shielded patients
If a child is a household contact of someone on the NHS shielded patients list,
or an immunocompromised person, they should also be offered the
vaccination.
In the CYPSE, any child who is sharing a room (or is in a unit similar to a
household setting) with a shielding child, long term or over the winter, should
be offered the flu vaccine.
Pregnant young women
Any girls in the CYPSE who are pregnant should be encouraged to have the flu
vaccination. Healthcare staff should consider vaccinating their babies, who are
eligible if they are in a risk group when they are born.
CYPSE staff
Different settings across the CYPSE will have different occupational health
arrangements for residential, care and healthcare staff, so it’s important to
include staff vaccination as part of flu preparation planning. It is important that
the CYPSE flu strategy contains clear information on vaccine coverage for all
appropriate staff groups.
All healthcare staff in direct contact with children and young people should be
offered a flu vaccination by their employer, similar to healthcare staff in the
community. This should form part of the establishment’s policy for preventing
flu transmission and should link directly to their occupational health policy.
This will help protect patients, and service users, as well as staff and wider
groups.
The NHS Specialist Pharmacy Service has published guidance for healthcare
providers on vaccinating their own staff. The written instruction uses a peer-to-
peer approach to maximise access to the vaccine for their employees.
All staff working in the CYPSE are eligible for the flu vaccine. Non-healthcare
staff working with children in the CYPSE who have close contact with children
and young people affected by flu are recommended to receive the seasonal flu
vaccine. This includes staff who:
check children in their rooms
undertake searches
provide food and drink
provide medication
provide other close personal care
Staff who are in clinical risk groups can access vaccine free of charge from their
GP practice or pharmacies participating in the NHS seasonal flu influenza
vaccination programme.
Occupational health providers should provide information to CYPSE senior
leaders on the number of staff in clinical risk groups and their vaccine status
(without providing patient identifiable information).
2.4 Vaccination targets, coverage and recording
The national flu immunisation programme for 2020 to 2021 has a number of
uptake ambitions, including:
vaccinating at least 75% of primary school-aged children
vaccinating at least 75% of children and young people in all clinical risk
groups
offering vaccination to 100% of healthcare workers and other non-healthcare
staff providing close personal care
Healthcare providers should record the offer and the uptake of the flu vaccine
to children and young people. Providers are encouraged to hold a register so
that they can identify all children eligible for the flu vaccine. Updating the
eligibility register throughout the flu season will help with coordinating the
local flu vaccination programme.
Risk group status should also be recorded on SystmOne or equivalent clinical
IT system. Providers should pay attention to including girls and young women
who could become pregnant and individuals who enter as risk groups during
the flu season.
For staff groups, healthcare workers should be included in their employers’
seasonal flu vaccination programme, in line with the national flu immunisation
programme. There is an uptake ambition of 100% given the additional concern
about flu outbreaks in closed secure settings.
For non-healthcare staff who have close contact with children and young
people, individual employers should tell them about the need to be vaccinated
and how to access vaccination through occupational health or other services.
Staff in clinical risk groups should receive a vaccine through their GP or a local
pharmacy participating in the NHS seasonal flu programme. This is free of
charge. Those not eligible through their employer or GP can access vaccination
privately if they want to, and they should be encouraged to consider this.
2.5 Accessing vaccine supplies
Healthcare providers access flu vaccines in the same way as GP practices, as
detailed in the chapter on influenza in the Green Book.
Vaccine supplies
Healthcare providers, or organisations that provide childhood vaccination
programmes to the CYPSE, should order flu vaccine supplies directly through
PHE’s ImmForm website.
Enough vaccine should be ordered based on past and planned performance
and expected demographic increase to make sure that everyone at risk is
offered a flu vaccine. Ordering controls are in place to reduce the amount of
excess vaccine ordered by NHS providers but not used. The latest information
on ordering controls and other ordering advice for vaccines will be available on
PHE’s vaccine update newsletter and on the ImmForm website.
In the event of an outbreak of seasonal flu, additional vaccine stock can be
sourced in priority order from:
ImmForm (providers will need to explain the basis of the increased need, as
this will exceed estimates for the current season or the outbreak could
happen outside the normal flu season)
pharmacy service providers contracted to provide pharmaceutical services
to the CYPSE
vaccine manufacturers
Administrating flu vaccines
Vaccines can be administered via a prescription or via a patient group direction
(PGD). A PGD is used for vaccinating a number of people. For example, as part
of nurse or pharmacist-led vaccination clinics. A PGD must be used in line with
legislation and National Institute for Health and Care Excellence (NICE)
guidance on PGDs.
PGDs should be in place all the time and reviewed in advance of the flu season.
This is so they are ready for use for flu vaccination clinics and when the Chief
Medical Officer advises the NHS that antivirals can be used for flu.
NHS England commissioners within individual regions or localities usually
authorise a flu vaccine PGD that can be shared and used by GP practices and
health and justice providers in that locality or region. Where providers cannot
access a local NHS England authorised PGD, the PHE template PGD for the
vaccine can be used by providers to either authorise within their organisation
(for NHS trusts) or to gain NHS England authorisation for its use (for non-NHS
healthcare providers).
3. Diagnosis and recognising a case
3.1 Flu symptoms
It is important that all staff (residential care as well as healthcare) are aware of
the symptoms of flu-like illness and of the need to quickly report possible cases
to healthcare.
Residential care staff often have the most contact with children and young
people, so are well-placed to recognise an increasing number of cases.
Staff with signs and flu-like symptoms should seek advice from their GP and
inform their line manager and occupational health provider.
If a young person is suspected of having flu, healthcare teams should assume it
is COVID-19. This means isolating them in line with the COVID-19 guidance for
prisons and secure settings, until laboratory testing confirms flu, or an
outbreak of flu has been confirmed by the outbreak control team (OCT).
The World Health Organization provides a useful case definition for flu cases:
an acute respiratory infection with a fever of 38°C or over and a cough,
beginning in the last 10 days.
People with COVID-19 may have similar symptoms to flu. PHE has published
information on case definitions for COVID-19.
3.2 Swabbing to confirm infection
CYPSE healthcare teams should swab the first few (up to 5) presenting cases,
requesting a full respiratory screen to include COVID-19 and flu as soon as
possible. Multiplex platforms that include both flu and COVID-19 are not
currently available, so 2 swabs are needed for every case – 1 for COVID-19
testing and 1 for flu or respiratory virus panel. These tests should be taken at
the same time, and put into separate tubes of viral transport media, with the
appropriate lab request forms.
While awaiting results implement COVID-19 infection prevention and control
measures. If the test results confirm COVID-19, staff will need to take action by
following COVID-19 guidance on investigation and initial clinical management
of possible cases.
If flu is confirmed and the OCT agrees, all other cases meeting the clinical case
definition can be regarded as suspected flu and no further testing is advised.
However, the OCT may consider further testing in particular parts of the
establishment towards the end of the outbreak. This might be because the
situation is complex, or to discount any possible new cases. It will also be
important to consider and test for COVID-19.
It is possible that laboratories will include tests for flu and COVID-19 in their
testing panel for respiratory infections but if multiplex platforms remain
unavailable, 2 swabs will be required as described above.
4. Population management and
preventing transmission
4.1 Isolating cases
CYPSE staff should isolate children presenting with flu symptoms in single
room accommodation and they should be clinically assessed as soon as
possible by the healthcare team. Initially, suspected cases should be assumed
to be COVID-19 cases and they should remain isolated until they have had a
healthcare assessment or had test results confirmed.
If there is a suspected case, CYPSE staff should continue to keep them
isolated until their symptoms resolve. This usually takes 5 days from the first
sign of flu symptoms but may be longer in people with underlying medical
conditions.
Different guidance applies to COVID -19, so it’s important that the correct
diagnosis is sought and the appropriate COVID-19 guidance followed. COVID-
19 guidance on preventing and controlling outbreaks in prisons is available.
4.2 Cohorting cases
Where demand for single room accommodation exceeds capacity, cases may
be ‘cohorted’ or paired together in a shared room (doubling up).
Where cases are concentrated in a particular unit or part of the secure setting,
the OCT can consider cohorting all other cases in the same place, but this may
not be possible. Healthcare teams should cohort cases of flu separately from
suspected or confirmed cases of COVID-19.
4.3 Asymptomatic contacts
Where there are 2 or more young people in a room and one is suspected or
confirmed as having flu, the other cellmates can pose an infection control risk.
This is because they could be asymptomatic (show no signs of being infected).
Where children and young people stay in small groups or ‘bubbles’, the same
may apply to the whole group or bubble.
These young people should be isolated for 48 hours starting from their last
contact with the suspected or confirmed case. However, this should be
reviewed if a COVID-19 test result is known.
Practical operational considerations, such as the number of spare rooms
available, will inform any decisions about whether the young person stays
where they are or are moved to another location away from the ill roommate.
4.4 Visiting
CYPSE staff should exclude symptomatic visitors until they are no longer
symptomatic. They should also discourage visitors with underlying health
conditions and those at risk of more severe infection from visiting during an
outbreak.
To protect patient welfare, CYPSE staff should keep visitor access to
symptomatic children and young people to a minimum. They should also
provide any visitors with hygiene advice. Non-urgent visits should be
rescheduled until after the outbreak is over.
5. Treatment and care
Children with symptoms should be offered bed rest and oral fluids with
paracetamol or ibuprofen as clinically indicated.
Healthcare staff can use antivirals for prophylaxis and treatment of influenza
according to NICE guidance for preventing flu and NICE guidance for treating
flu. These guidelines remain an integral part of flu control measures for closed
secure settings.
PHE has also published guidance on the use of antivirals.
Healthcare staff should consider treating children and young people with
suspected flu that are in clinical risk groups with antivirals. This is usually
oseltamivir, or more commonly known as Tamiflu. PHE recommends
considering antiviral treatment even in vaccinated children and young people.
5.1 Antiviral post-exposure prophylaxis of close
contacts
Healthcare staff should use antivirals for post-exposure prophylaxis (AV-PEP)
for those contacts of cases that are in clinical risk groups. This is regardless of
their seasonal flu vaccine status (although this lies outside of NICE guidance).
Where there is an extensive outbreak, the OCT should consider offering AV-PEP
to all children and young people in clinical risk groups in affected parts of or
throughout the secure setting.
5.2 Accessing supplies of antivirals
CYPSE flu plans should include details of the ordering process and supply of
antivirals. These plans need to consider the need for patients to start antivirals
within 36 to 48 hours of symptoms beginning, as appropriate.
Healthcare staff should record all supplies of antivirals given to children in their
clinical records. They can give Tamiflu ‘in-possession’ unless the child or young
person is unable to manage their medicines. This means the child or young
person keeps their medication in their room.
Alternative antivirals are available for patients who are unable to take Tamiflu.
There are 2 ways for children to access antivirals following a clinical
assessment and diagnosis:
1. Individual prescriptions or a patient specific direction.
Healthcare staff can access antivirals by sending the prescription or patient-
specific direction to the pharmacy for dispensing. This will be the pharmacy
contracted to provide medicines to the CYPSE or an out-of-hours pharmacy.
Healthcare staff can also use ‘over-labelled’ stock supplies that allow the
prescriber or registered healthcare professional to add the patient’s name and
date to the pack. This means they can give the antivirals directly to the patient
without waiting for them to come from the pharmacy. This should be
completed using standard operating procedures developed and approved by
the healthcare provider.
2. A patient group direction.
Healthcare staff should only use a PGD in line with legislation and NICE
guidance on PGDs. PGDs can help healthcare staff quickly access the flu
vaccine and antivirals.
PHE has produced 2 PGD templates for flu AV-PEP and treatment. The
templates were designed for use in care homes only, but they can be adapted
for secure settings. The PGDs cover:
Tamiflu for the treatment of flu-like symptoms
Tamiflu for the prophylaxis of people at risk of getting the flu and who meet
specific criteria
The healthcare professional who assesses the child or young person must hand
Search on GOV.UK
Contents
1. Introduction
2. Preparation and
vaccination
3. Diagnosis and
recognising a case
4. Population
management and
preventing transmission
5. Treatment and care
6. Outbreaks in the
CYPSE
Coronavirus (COVID-19)
Coronavirus (COVID-19): guidance and support
The UK has left the EU
Check the new rules for January 2021
Benefits
Births, deaths, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
Money and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions
Services and information Departments and policy
How government works
Departments
Worldwide
Services
Guidance and regulation
News and communications
Research and statistics
Policy papers and consultations
Transparency and freedom of
information releases
Is this page useful?
 
Help  Privacy  Cookies  Contact  Accessibility statement  Terms and conditions
Rhestr o Wasanaethau Cymraeg  Built by the Government Digital Service
© Crown copyright
The healthcare professional who assesses the child or young person must hand
them the in-possession medication supplied under a PGD. For non-in-
possession supplies, the healthcare professional who assesses the child or
young person can supply the antiviral to healthcare staff for storage so that
doses can be administered under supervision in line with local arrangements.
The antiviral supplied via a PGD must be from over-labelled stock and the name
of the patient and the date added to the label by the healthcare professional.
During an outbreak, PHE may recommend considering post-exposure
prophylaxis with antiviral medication for staff in clinical risk groups. This would
usually be provided by a GP. Some outbreaks may need a longer duration
prophylaxis option for high-risk people.
A healthcare professional can give a high-risk person Tamiflu for prophylaxis for
up to 42 days according to the product licence.
If a PGD is not in place when an outbreak becomes likely or begins,
commissioners and providers can write prescriptions for antivirals or flu
vaccinations until a PGD is in place.
NHS trust healthcare providers can authorise their own PGDs and so can fast
track the development and authorisation of PGDs for flu vaccine and Tamiflu.
Non-NHS providers cannot authorise their own PGDs, but they should have a
mechanism to write the PGD and submit it for authorisation by the NHS
England local commissioner. Health and justice commissioners need to identify
who the PGD authoriser is for their local team and help the rapid PGD
authorisation through this local process.
5.3 Stock access of flu vaccine and antivirals
Flu vaccine is supplied from ImmForm for people under 18 years old.
Antivirals supplied under a PGD are usually sourced already over-labelled from
the provider’s usual supplier of pre-packs and over-labelled medicines. For
urgent supply during an outbreak it is acceptable for the antiviral to be
supplied by adding the patient name, date and site name to the manufacturer’s
pack. The healthcare professional will then need to give verbal instructions to
the patient about the dose, advising them to read the patient leaflet in the
pack and to contact healthcare staff if they have any queries while taking it.
You can find more information on PGDs on the Specialist Pharmacy Service
website.
In an outbreak, commissioners should check and confirm they have access to
enough antiviral stock. They may need support to access urgent stock, which
PHE can help with.
Emergency regional stocks are a last resort. The pharmacy would need to hold
the supply of antivirals and all costs for replacing them and pharmacy charges
would be directly reimbursed by the commissioner.
Where stock supplies of over-labelled antivirals are used, plans should include:
agreed minimum stock levels based on the previous year’s use with plans to
amend this during an outbreak
processes to check the antiviral stock regularly to ensure appropriate
storage and expiry dates, audit the supplies made and reorder stock should
this fall below minimum levels
6. Outbreaks in the CYPSE
If staff suspect or confirm a seasonal flu outbreak, the PHE health and justice
team strongly recommends that local PHE health protection teams arrange an
OCT meeting. You can find more information on managing outbreaks in the
Multi-agency contingency plan for disease outbreaks in prisons guidance.
The OCT will:
review information with partners on the extent and severity of infection
(including information on patients requiring transfer out to hospital)
collect data on clinical attack rates to guide management of effective
control measures
review and advise on infection control practice
consider vaccine coverage among children and staff groups
consider role of antiviral treatment or prophylaxis for cases or contacts
including staff
You should invite the national PHE health and justice team who can provide
expert support. You can contact them by email at health-justice@phe.gov.uk.
You should also consider inviting representatives from PHE’s field
epidemiology services team and the National Infection Service as contributors
to the OCT.
The HMPPS health liaison service should also be routinely invited to join OCT
meetings. You can contact them by email at health@justice.gov.uk.
During an OCT meeting, the following questions need to be considered:
1. Has testing for seasonal flu, COVID-19 and other respiratory infections been
carried out (see section on swabbing)?
2. Is there a need to offer vaccination to the children and young people, as well
as staff?
3. Is antiviral prophylaxis needed and who should receive it and how? This
includes confirming that a current in-date PGD is in place.
4. What is the operational status of the secure setting? This includes any
restrictions that are in place, such as a temporary stop to transfers in and
out of the establishment.
5. Should children and young people be isolated or cohorted as part of wider
infection control practice?
6. Are the appropriate staff either dealing with children who are symptomatic
or asymptomatic but not both?
7. Is there a process for managing hospital admissions if needed?
8. Is there a process for dealing with communication and media issues?
Specific infection control considerations:
1. Re-emphasise hand and respiratory hygiene measures to help minimise the
spread of the infection (for young people and staff).
2. Use chlorine-based bleach products to disinfect and deep clean
contaminated areas for infection control purposes. HMPPS has approved
Titan Chlor tablets.
3. If a symptomatic case needs to pass through areas where other people are
waiting, then they should wear a fluid repellent surgical mask.
4. Residential healthcare staff who are assessing children with suspected flu
and coming into close contact (less than 1 metre) to provide care should
wear appropriate PPE.
5. During any outbreak, residential and healthcare staff and custodial staff with
flu-like symptoms should be excluded from work and be managed by their GP
if they are in specific clinical risk groups. They may also need to seek COVID-
19 testing in line with local testing pathways.
6. If staff become ill at work, they should be sent home immediately or isolated
until they can be sent home.
7. Report cases among staff and children and young people to the health
protection team.
Specific considerations about communications during an outbreak:
1. PHE may recommend that staff in clinical risk groups should be considered
for post-exposure prophylaxis with antiviral medication. You can download
an information leaflet for staff about using antiviral medication to treat and
prevent seasonal flu.
2. Issuing a letter to staff to inform them of the outbreak and provide relevant
advice.
6.1 Specific considerations for the CYPSE around
population management during an outbreak
Where an outbreak has been declared, the governor, director or manager and
the PHE consultant in health protection leading the OCT should complete a
dynamic risk assessment form.
The OCT may consider recommending:
1. Restricting transfers out to other secure settings.
This is to avoid ‘seeding’ or starting an outbreak in other secure settings.
Where it’s required for security reasons, notify the receiving secure setting of
the outbreak. Avoid transferring symptomatic children as a priority. If a transfer
is required, follow all infection control advice.
Recommendations to restrict transfers in and out of an establishment will
require consideration by HMPPS at a national level.
2. Restricting new receptions.
This is to avoid ‘feeding’ or making an outbreak worse by introducing new
vulnerable cases to the establishment. If it is not possible to restrict new
receptions completely, they should be:
assessed to determine if they are in a risk group and considered for AV-PEP
and vaccine
assessed for signs and symptoms of flu and symptomatic children who have
just arrived at the secure setting should be isolated or cohorted immediately
swabbed and considered for a treatment dose of antivirals and isolation or
cohorting if they are symptomatic and in a risk group, and it’s clinically
appropriate
6.2 Restricting arrivals and transfers
When a secure setting is considering limiting movement to arrivals and
transfers in the CYPSE, the decision will be taken by the OCT working with the
YCS or individual secure children’s homes (SCH) using the following steps.
1. The OCT should consider whether limiting movement should be to arrivals or
transfers out of the CYPSE only, for instance working out if there is an
unaffected part of the secure setting that can be used. This is so it can
continue to accept new children and maintain HMPPS’ service to the youth
or family courts, placing local authorities and also the Police and Criminal
Evidence Act 1984 and directors of children’s services’ directives.
2. The OCT should consider whether full or partial movement limitation is
necessary. They should obtain (via the governor, director or manager) from
the YCS placement team or an impact assessment of change in ability to
receive new children or make transfers.
3. The impact assessment will consider how restrictions on reception or
discharge will affect surrounding CYPSE, and how long the restrictions are
sustainable.
4. The OCT must consider the impact assessment before they decide whether
to recommend to the YCS head of placements to change activity, limit
movement or close. The secure welfare coordination unit (SWCU) should be
notified where any decisions will have an impact on the secure welfare
estate.
5. Only the YCS director or deputy director, or the HMPPS gold commander
should take decisions on closing a young offender institution, secure training
centre or SCH to receptions and transfers. This is because they have
oversight of a greater proportion of the children and young people’s estate
and will understand how a decision to close will have on the wider young
offender population. The registered SCH manager will be responsible for
deciding to close to new admissions or transfers, consulting with the YCS
where relevant and notifying the SWCU about any decision taken on new
welfare admissions.
6. The OCT, YCS director or deputy director or SCH registered manager may
want to limit movement, change activity or close the secure setting for a
longer period than the YCS placement team, WCU, or placing authority
thinks is sustainable (in some circumstances, these actions might not be
deemed sustainable for any time at all). In this situation, their
recommendation must be escalated to the YCS director or HMPPS gold
commander for a final decision.
7. If an urgent out-of-hours decision is required, it should be made by
appropriate senior director on duty.
8. If a decision to limit movement, change activity or close is taken, a further
impact assessment of continuing closure must be obtained from the YCS
placement team or SCH registered manager at least every 3 days.
9. The assessment should be provided to the YCS director along with up-to-
date information about the current status of the outbreak.
10. The YCS director or registered manager should then maintain or withdraw
their decision to limit movement, change activity or close the establishment
to receptions and transfers.
11. If the YCS placement team or SCH registered manager’s assessment says
that continuing change of activity or closure is unsustainable, any decision to
extend the change of activity must be made by the YCS director (or duty
director in an urgent out of hours situation).
6.3 Transfers to court
In an outbreak situation, symptomatic children and young people may not be
suitable for court due to clinical needs and infection control considerations.
Courts should be told that a child or young person is ill with flu and so may not
be suitable for a court appearance.
If a symptomatic child or young person needs to attend court, a video link to
the court should be considered as an alternative to a personal appearance.
If a personal appearance is required, appropriate infection control measures
should be implemented following COVID-19 guidance on courts and tribunals
planning and preparation.
6.4 New allocations from court
Consideration should be given to redirecting new children and young people
who have been allocated to an infected site. However, this may only be
sustainable for a few days at most.
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